Bruce Bean

Bruce Palmer Bean, PhD

Robert Winthrop Professor of Neurobiology

Bruce Palmer Bean, PhD – Faculty Profile

If you prefer, you can view the visual layout directly on Canva: Open Bruce Palmer Bean – Faculty Profile on Canva (opens in a new window) .

Title: Robert Winthrop Professor of Neurobiology, Harvard Medical School.

The Aim

The Bean Lab studies the pharmacology of ion channels that govern the electrical activity of neurons. Neuronal activity is regulated by molecular gates in the cell membrane called ion channels.

The Impact

Different types of neurons express different combinations of ion channels, which is why they fire differently and serve different functions. The Bean Lab uses pharmacology to study how ion channels differentially regulate electrical activity in particular kinds of neurons, both characterizing existing ion channel–targeted drugs and developing new ones. This approach has contributed to the development of new compounds that target channels in pain‑sensing neurons without the side effects and risks associated with opioids. Ongoing projects aim to develop new drugs targeting chronic pain, epilepsy, and multiple sclerosis.

A Closer Look

Article: “This Will Have a Negative Effect on the Entire Drug‑Development Enterprise” , Harvard Medicine Magazine, July 2025. This perspective explains how Bruce Bean’s lab uses basic research on neuronal ion channels and hyperexcitability to identify new, safer drug targets for pain and epilepsy, positioning the lab as an early‑stage engine for future non‑opioid therapies.

Article: The Discovery Channel: Why do Harvard doctors remain undaunted by the demands of discovery? , Harvard Medicine Magazine, Spring 2011. This feature describes how Harvard is boosting drug discovery by supporting risky early‑stage projects and collaborations; Bruce Bean’s ion‑channel research is highlighted as an example of identifying new targets for pain and epilepsy treatments that industry can later develop into drugs.

Contact

Email: bruce_bean@hms.harvard.edu

Publications View
Anthrax toxins regulate pain signaling and can deliver molecular cargoes into ANTXR2+ DRG sensory neurons.
Authors: Authors: Yang NJ, Isensee J, Neel DV, Quadros AU, Zhang HB, Lauzadis J, Liu SM, Shiers S, Belu A, Palan S, Marlin S, Maignel J, Kennedy-Curran A, Tong VS, Moayeri M, Röderer P, Nitzsche A, Lu M, Pentelute BL, Brüstle O, Tripathi V, Foster KA, Price TJ, Collier RJ, Leppla SH, Puopolo M, Bean BP, Cunha TM, Hucho T, Chiu IM.
Nat Neurosci
View full abstract on Pubmed
Developing nociceptor-selective treatments for acute and chronic pain.
Authors: Authors: Jayakar S, Shim J, Jo S, Bean BP, Singeç I, Woolf CJ.
Sci Transl Med
View full abstract on Pubmed
Bidirectional flow of the funny current (If) during the pacemaking cycle in murine sinoatrial node myocytes.
Authors: Authors: Peters CH, Liu PW, Morotti S, Gantz SC, Grandi E, Bean BP, Proenza C.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
Cannabidiol inhibition of murine primary nociceptors: Tight binding to slow inactivated states of Nav1.8 channels.
Authors: Authors: Zhang HB, Bean BP.
J Neurosci
View full abstract on Pubmed
Inhibition of inflammatory pain and cough by a novel charged sodium channel blocker.
Authors: Authors: Tochitsky I, Jo S, Andrews N, Kotoda M, Doyle B, Shim J, Talbot S, Roberson D, Lee J, Haste L, Jordan SM, Levy BD, Bean BP, Woolf CJ.
Br J Pharmacol
View full abstract on Pubmed
BK channel regulation of after-potentials and burst firing in cerebellar Purkinje neurons.
Authors: Authors: Niday Z, Bean BP.
J Neurosci
View full abstract on Pubmed
Lidocaine binding enhances inhibition of Nav1.7 channels by the sulfonamide PF-05089771.
Authors: Authors: Jo S, Bean BP.
Mol Pharmacol
View full abstract on Pubmed
Vagal sensory neurons drive mucous cell metaplasia.
Authors: Authors: Talbot S, Doyle B, Huang J, Wang JC, Ahmadi M, Roberson DP, Yekkirala A, Foster SL, Browne LE, Bean BP, Levy BD, Woolf CJ.
J Allergy Clin Immunol
View full abstract on Pubmed
Novel charged sodium and calcium channel inhibitor active against neurogenic inflammation.
Authors: Authors: Lee S, Jo S, Talbot S, Zhang HB, Kotoda M, Andrews NA, Puopolo M, Liu PW, Jacquemont T, Pascal M, Heckman LM, Jain A, Lee J, Woolf CJ, Bean BP.
Elife
View full abstract on Pubmed
Publisher Correction: Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug.
Authors: Authors: Barak B, Zhang Z, Liu Y, Nir A, Trangle SS, Ennis M, Levandowski KM, Wang D, Quast K, Boulting GL, Li Y, Bayarsaihan D, He Z, Feng G.
Nat Neurosci
View full abstract on Pubmed